Parsons Capital Management Inc Relmada Therapeutics, Inc. Call Options Transaction History
Parsons Capital Management Inc
- $1.44 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding RLMD
# of Institutions
98Shares Held
14.2MCall Options Held
82KPut Options Held
73.9K-
Vanguard Group Inc Valley Forge, PA1.26MShares$5.23 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.24MShares$5.16 Million0.19% of portfolio
-
Vestal Point Capital, LP New York, NY1.2MShares$4.99 Million0.46% of portfolio
-
Acadian Asset Management LLC Boston, MA1.18MShares$4.91 Million0.02% of portfolio
-
Opaleye Management Inc. Boston, MA759KShares$3.16 Million0.86% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $119M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...